---
title: Waiting for Genomic Test Results to Start Treatment Can Improve OS in NSCLC
description: Trilaciclib was found to to be a promising new treatment for chemotherapy-induced myelosuppression prevention and other benefits for patients with extensive-stage small cell lung cancer.
---

[Newsroom ](https://insights.integraconnect.com/news)

# [Waiting for Genomic Test Results to Start Treatment Can Improve OS in NSCLC](https://insights.integraconnect.com/news/waiting-for-genomic-test-results-to-start-treatment-can-improve-os-in-nsclc)

 Written by [Integra Connect](https://insights.integraconnect.com/news/author/integra-connect) | Aug 22, 2023 12:00:00 PM

Click here to [read the original article at Targeted Oncology.](https://www.targetedonc.com/view/genomic-testing-and-targeted-therapies-may-be-underused-in-community-practice-study-shows)

[View full post](https://insights.integraconnect.com/news/waiting-for-genomic-test-results-to-start-treatment-can-improve-os-in-nsclc)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Integra Connect"
  },
  "dateModified" : "2023-09-19T23:55:05.747Z",
  "datePublished" : "2023-08-22T12:00:00Z",
  "headline" : "Waiting for Genomic Test Results to Start Treatment Can Improve OS in NSCLC",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://insights.integraconnect.com/news/waiting-for-genomic-test-results-to-start-treatment-can-improve-os-in-nsclc",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Newsroom"
  }
}
```